Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-09
2011-08-09
Hui, San-Ming (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S311000, C514S314000
Reexamination Certificate
active
07994189
ABSTRACT:
The present invention relates to dihydropyridine derivatives having general formula (I) or a pharmaceutically acceptable salt thereof, wherein R1is (1-6C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl, phenyl, (1-5C)heteroaryl R2, R3are independently (1-4C)alkyl, (2-4C)alkenyl, (2-4C)alkynyl, (1-4C)alkoxy, (24C)alkenyloxy, (2-4C)alkynyloxy, halogen X is SO2, CH2, C(O) or X is absent R4is (1-6C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl, (3-6C)cycloalkyl, (3-6C)cycloalkenyl, (3-6C)cycloalkyl(1-4C)alkyl, (2-6C)heterocycloalkyl, (2-6C)heterocycloalkyl(14C)alkyl, (6-1 OC)aryl, (6-10C)aryl(1-4C)alkyl, (1-9C)heteroaryl or (1-9C)heteroaryl(14C)alkyl. The compounds are useful for the treatment of fertility disorders.
REFERENCES:
patent: 6087503 (2000-07-01), Furuya et al.
patent: 6194428 (2001-02-01), Urbahns et al.
patent: 2008/0262033 (2008-10-01), Karstens et al.
patent: 2008/0275042 (2008-11-01), Poveda et al.
patent: 2008/0300270 (2008-12-01), Timmers et al.
patent: 1070162 (1959-12-01), None
patent: 0 755 931 (1997-01-01), None
patent: 2003026630 (2003-01-01), None
patent: WO 94/08966 (1994-04-01), None
patent: WO 96/06610 (1996-03-01), None
patent: WO 00/08015 (2000-02-01), None
patent: WO 00/78768 (2000-12-01), None
patent: WO 02/09706 (2002-02-01), None
patent: WO 03/004028 (2003-01-01), None
patent: WO 2004/056779 (2004-07-01), None
Altmayer, et al., “Propofol Binding to Human Blood Proteins”,Arzneim.-Forsch./Drug Res. (1995) 45: 1053-1056.
Anelli et al., “Smiles Rearrangement as a Tool for the Preparation of 5-[(2-Hydroxyacyl)amino]- 2,4,6-triiodo-1,3-benzenedicarboxamides: Main Pathway and Side Reactions,”Tetrahedron(1997) 53:11919-11928.
Aranyos, et al., “An Application of the Stille Coupling for the Preparation of Arylated Phthalonitriles and Phthalocyanines”,Acta Chem. Scand. (1999) 53: 714-720.
Bahner, et al., “Halogenated Aminobenzaldehydes and Aminostyrylquinolines”,J. Org. Chem, 25 (1960) 2053-2055.
Baker, William R. “Alkoxide-Accelerated Smiles Rearrangements. Synthesis of N-(2-Hydroxyethyl)anilines from N-(2-Hydroxyethyl) (aryloxy)acetamides,”J. Org. Chem. (1983) 48: 5140-5143.
Bierbaum et al., “Hypotensive 1,2,4-Benzothiadiazines,”J. Med. Chem. (1963) 6: 272-275.
Claibome et al., “Orally Efficacious NR2B-Selective NMDA Receptor Antagonists,”Bioorg.&Med. Chem. Lett. 13:697-700, 2003.
Crich, et.al., “Enantiospecific Synthesis with Amino Acids. Part 2. a-Alkylation of Tryptophan: A Chemical and Computational Investigation of Cyclic Tryptophan Tautomers”,J. Chem. Soc. Perkin Trans. 2 (1992) 2233-2240.
Devroey, et al., “Successful in-vitro fertilisation and embryo transfer after treatment with recombinant human FSH”,Lancet339 (1992) 1170-1171.
Dondoni et al., “Two- and Three-Component Hantzsch Reaction Using C-Glycosylated Reagents. Approach to the Asymmetric Synthesis of 1,4-Diyhydropyridines”,Synlett(2002) 89-92.
Dorrington & Armstrong, “Effects of FSH on Gonadal Functions”,Recent Prog. Horm. Res., 35 (1979) 301-342.
Dow, et al., “Discovery of a Novel Series of 6-Azauracil-Based Thyroid Hormone Receptor Ligands:Potent, TRβ Subtype-Selective Thyromimetics”,Bioorg.&Med. Chem. Lett. 13 (2003) 379-382.
Drizin, et al., “Structure-Activity Studies for a Novel Series of Tricyclic Dihydropyrimidines as KATP Channel Openers (KCOs)”,Bioorg.&Med. Chem. Lett. 12 (2002) 1481-1484.
Eisner, et al., “The Chemistry of Dihydropyridines”,Chem. Rev. 72 (1972) 1-42.
Fisher, et al., “Heteroatom-Directed Metalation. Lithiation of N-Propenylbenzamides and N-Propenyl-o -toluamides. Novel Routes to Ortho-Substituted Primary Benzamide Derivatives and N-Unsubstituted Isoquinolin-1(2H)-ones”,J. Org. Chem. 57 (1992) 2700-2705.
Fukuyama, et al., “2,4-Dinitrobenzenesulfonamides: A Simple and Practical Method for the Preparation of a Variety of Secondary Amines and Diamines”,Tetrahedron Lett. 38 (1997) 5831-5834.
Greiner, A., “TDA-1 Catalysis in Smiles Rearrangement of N-Arylphenoxyamides. Accelerating Effect of the 2,4,6-Trichloro Substitution,”Tetrahedron Lett. 30:931-934, 1989.
Guilford, et al., “Synthesis, Characterization, and Structure-Activity Relationships of Amidine-Substituted (Bis)benzylidene-Cycloketone Olefin Isomers as Potent and Selective Factor Xa Inhibitors,”J. Med. Chem. 42:5415-5425, 1999.
Guo, et al., “Enantioselective Addition of Diethylzinc to Benzaldehyde Catalyzed by Chiral Titanate Complexes with Helical Ligands”,Tetrahedron53 (1997) 4145-4158.
Harvey, et al., “o-Nitroaniline Derivatives. Part 11. 4- and 7-Amino-IH-benzimidazole 3-Oxides”,J. Chem. Soc. Perkin Trans. 1 (1988) 1939-1943.
Insler, V., “Gonadotropin Therapy: New Trends and Insights”,Int. J. Fertil., 33 (1988) 85-97.
Jia, et al., “Expression of Human Luteinizing Hormone (LH) Receptor: Interaction with LH and Chorionic Gonadotropin from Human but not Equine, Rat, and Ovine Species”,Mol. Endocrinol. 5 (1991) 759-768.
Kansal, et al., “Diuretic Agents: Synthesis of 1,2-Disubstituted 7-Sulphamoylbenzimidazole-5-Carboxylic Acids,”Indian J. Chem. 18B:88-90, 1979.
Katsumi, et al., “Studies on Styrene Derivatives. I. Synthesis and Antiinflammatory Activities of a-Benzylidene-γ-butyrolactone Derivatives”,Chem. Pharm. Bull. 34 (1986) 121-129.
Kesten, et al., “Synthesis and Antimalarial Properties of 1-Imino Derivatives of 7-Chloro-3-substituted-3,4-dihydro-1,9(2H,10H)-acridinediones and Related Structures”,J. Med. Chem. 35 (1992) 3429-3447.
Krohn, et al., “Total Synthesis of Angucyclines. Part 15: A Short Synthesis of (±)-6-Deoxybrasiliquinone B”,Tetrahedron56 (2000) 4753-4758.
Kuehne, et al., “1,4-Dihydrobenzoic Acid”,Org. Synth. Coll. 5 (1973) 400.
Kumar, et al., “Synthesis and Evaluation of Anticancer Benzoxazoles and Benzimidazoles Related to UK-1”,Bioorg.&Med. Chem. 10 (2002) 3997-4004.
Lal, et al., “Regiospecific Oxidation by DDQ Of Unhindered Alkyl Groups In Sterically Hindered Aromatic Amines”,Tetrahedron Lett. 25 (1984) 2901-2904.
Langry, K.C., “Synthesis Of Imidazoquinolines And Imidazoisoquinolines From Azanaphthalene Carboxylic Acids”,Org. Prep. Proced. Int. 26 (1994) 429-438.
Larget, et.al. “A Convenient Extension of the Wessely-Moser Rearrangement for the Synthesis of Substituted Alkylaminoflavones as Neuroprotective Agents In Vitro”,Bioorg.&Med. Chem. Lett. 10 (2000) 835-838.
Lavilla, R., “Recent developments in the chemistry of dihydropyridines”,J. Chem. Soc., Perkin Trans. 1 (2002) 1141-1156.
Loev, et al., “Hantzsch-Type Dihydropyridine Hypotensive Agents”,J. Med. Chem. 17 (1974) 956-965.
Manchand, et al., “Synthesis of 3,4,5-Trimethoxybenzaldehyde”,Synth. Commun. 20 (1990) 2659-2666.
Mariella, et al., “Synthesis of Some Aromatic Malononitriles”,J. Org. Chem. 23 (1958) 120-121.
Mayer, et.al., “Über Carbocyclische Reduktone. Dihyrogpyogallol und Dihydrogallussäure”,Chem. Ber. 88 (1955) 316-327.
McCarthy, et al., “Synthesis and Renal Vasodilator Activity of 2-Chlorodopamine and N-Substituted Derivatives,”J. Med. Chem. 29: 1586-1590 (1986).
Miri, et al., “Synthesis and Calcium Channel Modulating Effects of Modified Hantzsch Nitrooxyalkyl 1,4-Dihydro-2,6-dimethyl-3-nitro-4-(pyridinyl or 2-trifluoromethylphenyl)-5-pyridinecarboxylates”,Drug Dev. Res. 51 (2000) 225-232.
Mitchell, et al., “N-Bromosuccinimide-Dimethylformamide: A Mild, Selective Nuclear Monobromination Reagent for Reactive Aromatic Compounds”,J. Org. Chem. 44 (1979) 4733-4735.
Morse, et al., “Hetrogeneity of Proteins in Commercial Preparations of Human Chorionic Gonadotropin (hCG) Demonstrated by Western Blotting”,Amer. J. Reproduct. Immunol. and Microbiology1
Gerritsma Gerritdina Geziena
Van Der Veen Lars Anders
Van Straten Nicole Corine Renee
Camara Valerie J.
Hui San-ming
N.V. Organon
Shatynski Patricia A.
LandOfFree
Dihydropyridine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydropyridine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydropyridine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2728390